Chris Myatt, PhD, Founder and Chief Executive Officer
Dr. Myatt is the founder and CEO of MBio Diagnostics. Prior to MBio Diagnostics, Chris founded and led Precision Photonics Corporation, a successful laser and optical technology supplier that is now a division of IDEX. Trained as a physicist and measurement scientist, Chris invented and developed multiple technologies that formed the basis of his companies. He earned a B.S. in Physics and a B.A. in Mathematics at Southern Methodist University. Chris also earned a Ph.D. in Atomic Physics at the University of Colorado. He studied Bose-Einstein Condensation (BEC) under Carl Wieman (Nobel Prize, 2001), helping to create the first BEC condensate in the Wieman lab. He also studied quantum information under David Wineland (Nobel Prize, 2012) as a National Research Council (NRC) Postdoctoral Fellow at the National Institute of Standards and Technology (NIST) in Boulder.
Byron Hewett, MBA, President, Diagnostics Division
Byron Hewett has led healthcare and life science companies for more than 30 years, in multi-national firms, development-stage and start-up companies. Byron is a 4-time CEO, including Brava Diagnostics. Prior to Brava, Byron was CEO of SomaLogic, a life sciences tools company focused on biomarker discovery. He served as Chairman and CEO of BioBehavioral Diagnostics, a start-up medical device company with the first FDA-cleared system for the assessment of ADHD. He served as CEO and a director at Immunicon (NASDAQ: IMMC), the first FDA-cleared test for circulating tumor cells. He served in executive roles at Qiagen, Bayer Diagnostics, Chiron Diagnostics and Abbott.
Byron earned a Masters in Management from Northwestern University’s J.L. Kellogg Graduate School of Management and a Bachelor’s of Science degree from the University of Virginia’s McIntire School of Commerce.
Mike Lochhead, PhD, Chief Technical Officer
Dr. Lochhead is a co-founder of MBio and leads technical development, collaborator activities, and intellectual property strategy. He serves as Program Manager on MBio’s commercial partnerships and is Principal Investigator on multiple major contracts with agencies including NIH, NSF and DARPA. Mike leads MBio’s talented team of instrumentation engineers and assay development scientists, and he has overall responsibility for operational scale-up of MBio’s disposable cartridge production line. Previously, Mike developed and commercialized microarray surface chemistry products at Accelr8 Technology Corporation (now Accelerate Diagnostics, Inc) where he was also part of the engineering team developing the company’s bacterial identification technology.
Dave Okrongly, PhD, Chief Science Officer
Dave Okrongly has been a business executive and R&D leader in the diagnostics industry, ranging from start-up to multi-national companies. He brings expertise in instrument and assay development, clinical/regulatory affairs and operations. Prior to joining Brava, Dave served as President of the OPKO Diagnostics division of OPKO Health, Inc. (NASDQ: OPK). He led the development and launch of the 4Kscore test for aggressive prostate cancer risk determination, and the development of the FDA-approved Claros 1 point-of-care analyzer. He served as chief operating officer of Exosome Diagnostics, President and CEO for Quanterix Corporation (NASDQ: QTRX), and held leadership positions with Siemens and Bayer Diagnostics.
Carrie Mulherin, MBA, Chief Marketing Officer
Carrie Mulherin is a marketing and sales executive with extensive start-up experience and 31 product launches. Carrie brings deep experience in strategic marketing, cross-functional team management and commercialization. Carrie was CEO of Focus Marketing, an independent consulting agency, VP of Diagnostics at SomaLogic, VP of Marketing and Sales for BioBDx/Pearson, Director of Marketing for Orasure Technologies, VP of Marketing and Sales at Immunicon Corporation and VP Sales and Marketing at Intracel Corporation.
Kenny Edwards, VP Finance, Chief Financial Officer
Kenny Edwards is an experienced, entrepreneurial CFO with over 25 years of diverse expertise in private and public company financial leadership. Kenny served as CFO for CenterStone Technologies, Inc., a privately held SaaS technology organization. Mr. Edwards led CenterStone’s successful 2018 acquisition. During his tenure, the organization identified, acquired and merged two organizations; one in the US and one in France.
Frank Gill, VP Operations
Frank is an entrepreneurial executive with over 20 years of experience building operational infrastructure and supply chains for IVD and Life Science companies, from initial start-up to worldwide commercial distribution. He has held senior leadership roles at 454 Life Sciences, Rheonix, iCarbonX and recently, as VP Operations & Site Head, led the turn-around of OPKO Diagnostics, culminating in the PMA approval of their Claros POC platform.
Frank earned his Bachelor of Science degree in Business Management from Albright College.
Nick Traggis, EVP, Corporate Development
Mr. Traggis has held various operations leadership, business development, and engineering positions in both industrial manufacturing and technology development companies. Most recently, he has served as a consultant performing C-level directed projects in areas of technology transfer, contract negotiation, and mergers/acquisitions for point of care diagnostics, and high-tech manufacturing companies. Prior to that he worked as the General Manager of Precision Photonics; ultimately selling to IDEX Corporation, where he remained on as the Chief Technology Officer. Mr. Traggis brings a strong deal-making expertise to our team as well as an ability to strategically evaluate current and emerging opportunities.
Katie Erdley, Director, Quality Assurance
Katie Erdley is an experienced director of quality assurance with marked success under the ISO 13485 Medical Device Single Audit Program. Katie has successfully designed, implemented, and maintained highly-compliant and efficient quality management systems for companies that develop and manufacture therapeutic and diagnostic medical devices. Prior to joining mBio, Katie was the Director of Quality Assurance at Actuated Medical Inc., where she was instrumental in the design and development, manufacturing scale up, and 510k clearance of the company’s first commercial medical device.
Katie earned her B.S. in Industrial Engineering from Penn State, completed the ExecuStar executive training program at the Penn State Harrisburg School of Business, and holds certificates from the American Society of Quality.
Kathy Crawford, Director, Human Resources
Kathy Crawford is an experienced Human Resources leader with a background growing cutting edge biosciences companies. Prior to joining MBio, Kathy served as Vice President, Human Resources for LivaNova, a global neuromodulation and cardiovascular medical technology organization. In addition, she has served in HR leadership roles at Arca Biopharma, Myogen, and Dharmacon /Fischer Scientific.
Kathy earned a BA in Philosophy from Wheaton College in Wheaton, Illinois and has attained several senior level HR certifications.
Sally Hatcher, JD, Corporate Secretary
Sally Hatcher, J.D. is a serial entrepreneur, advisor, startup accelerator faculty member, impact investor and board member. She co-founded and was President of two companies, including Precision Photonics, a laser & opto-electronics design and manufacturing company. Sally has worked with several digital women’s health companies, and spent a year as President/COO of Kindara. She regularly consults with diverse teams of innovators who want to spinout or start up a company. Sally’s business and law background comes from her time as a consultant with McKinsey & Co. and an Assistant Attorney General for Colorado. She sits on several boards and is active in environmental and women’s issues.